Allarity Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
ALLR on Nasdaq
Industry
Pharmaceutical Preparations
Location
24 School St., 2 Nd Floor, Boston, MA

There are no Buy or Sell transactions made by insiders since 11/9/2023

Allarity Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jeremy R. Graff President and Chief Development Officer $250K Sep 30, 2024
Alexander Epshinsky Chief Financial Officer $117K Sep 12, 2024
Gail J. Maderis Director Dec 20, 2021
Duncan Moore Director Dec 20, 2021
Marie Foegh Chief Medical Officer Dec 20, 2021
Soren Gade Jensen Director Dec 20, 2021
Steen Knudsen Chief Scientific Officer Dec 20, 2021
Thomas Jensen SVP, Information Technology Dec 20, 2021
Joan Brown Chief Financial Officer Jun 29, 2022
David Roth Director Jul 7, 2022
Gerald W. McLaughlin Director Oct 1, 2022
Joseph Vazzano Director Aug 1, 2023
James Cullem SVP, Chief Business Officer Dec 20, 2021
Jens Erik Knudsen Former Chief Financial Officer Jun 27, 2022
Laura Benjamin Director Aug 1, 2023
Leon Sass 10%+ Owner Dec 20, 2021
Steve Carchedi Chief Executive Officer, Director Dec 20, 2021

Recent Insider Transactions by Companies or Individuals for Allarity Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.